Aliment Capital grew out of Pontifax AgTech, a strategic partner of healthcare VC firm Pontifax Group, and evolved into a growth-stage investor that backs already-established food, agriculture, nutrition, and biopharma companies—focusing on crop inputs, gene editing, automation/robotics, and health/nutrition—rather than early-stage or mission-driven startups. Its second fund closed at $302 million, nearly triple its first fund, with about 70% of capital from new investors, and its approach includes advisors from major food and ag companies plus deals like Agrovision, which combined genetics, production, AI, and distribution under one company tied to changing consumer health trends such as GLP-1-driven produce demand.